SEC Form 4 · accession 0001638599-16-000610
ALBANY MOLECULAR RESEARCH INC · AMRI
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
George Svokos
Officer — Chief Operating Officer
Period of report
Jan 6, 2016
Accepted (ET)
Feb 5, 2016 · 4:13 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001065087
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jan 6, 2016 | A | 58 | $16.79 | A | 77,232 | D | |
| Common Stock | Feb 4, 2016 | F | 596 | $16.16 | D | 76,636 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1These shares were acquired under the Albany Molecular Research, Inc. Second Amendment 1998 Employee Stock Purchase Plan.
- F2Consists of shares withheld by Albany Molecular Research, Inc. in order to satisfy the minimum tax withholding obligation of the reporting person.